Today: 11 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Ondas Holdings (ONDS) Stock: Dec. 20 Weekend Roundup of New Defense Catalysts, Analyst Targets, and What Comes Next

Ondas Holdings (ONDS) Stock: Dec. 20 Weekend Roundup of New Defense Catalysts, Analyst Targets, and What Comes Next

Ondas Holdings Inc. is ending the week in the spotlight after a sharp rally that pushed the stock to a $9.22 close on Friday, Dec. 19, up 18.21% in a single session on heavy volume. The move caps off a volatile stretch in which Ondas has been issuing a fast cadence of defense-and-autonomy updates—while also filing capital-structure disclosures investors are now weighing into year-end positioning. StockAnalysis+1
21 December 2025
·
Infosys Limited Stock (INFY) Jolt: NYSE ADR Spike Triggers Halts; Company Says No Material Event

Infosys Limited Stock (INFY) Jolt: NYSE ADR Spike Triggers Halts; Company Says No Material Event

Dec. 21, 2025 — Infosys Limited stock became one of the market’s most talked-about names this weekend after its U.S.-listed American Depositary Receipts experienced an eye-catching — and largely unexplained — surge in New York trading. On Dec. 19, Infosys ADRs briefly jumped as high as the $30 area before pulling back sharply and ending the session around $20, a dramatic swing for a mega-cap IT services firm. MarketWatch+2Barron's+2
21 December 2025
·
Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

Amicus Therapeutics, Inc. has become one of the most closely watched rare-disease stocks heading into the final stretch of 2025 after BioMarin Pharmaceutical announced a definitive agreement to acquire Amicus in an all-cash transaction valued at about $4.8 billion. The offer price—$14.50 per share in cash—instantly reset the “center of gravity” for FOLD shares and shifted investor focus from traditional biotech catalysts to merger timing, regulatory approvals, and closing risk. SEC+1
21 December 2025
··
Plug Power (PLUG) Stock News on Dec. 20, 2025: Latest Updates, Analyst Forecasts, and the Key Catalysts Investors Are Watching

Plug Power (PLUG) Stock News on Dec. 20, 2025: Latest Updates, Analyst Forecasts, and the Key Catalysts Investors Are Watching

As of Saturday, December 20, 2025, Plug Power Inc. is back in the spotlight—but not for just one reason. The stock is being pulled between optimism around commercial electrolyzer wins and a potential data-center power angle, and concerns about dilution, cash burn, and the company’s path to sustainable profitability.
21 December 2025
··
Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery stock is no longer trading like a “normal” media equity. As of this weekend, WBD shares are moving like a merger-arbitrage instrument, tethered to two competing takeover paths: Netflix’s signed deal for WBD’s Studios + Streaming assets and Paramount Skydance’s hostile all-cash tender offer for the entire company. Reuters+2Warner Bros. Discovery IR+2
21 December 2025
···
BigBear.ai Stock (BBAI) News, Forecasts and Analyst Views on Dec. 20, 2025: Border-Security Partnership Fuels Momentum as Ask Sage Deal Looms

BigBear.ai Stock (BBAI) News, Forecasts and Analyst Views on Dec. 20, 2025: Border-Security Partnership Fuels Momentum as Ask Sage Deal Looms

BigBear.ai Holdings, Inc. is back in the spotlight heading into the Dec. 20, 2025 weekend after a sharp surge in the prior session reignited debate over whether the small-cap defense AI specialist is building a durable growth runway—or simply riding headline-driven volatility.
21 December 2025
···
NVIDIA Stock (NVDA) News, Forecasts and Analyst Outlook After Dec. 20, 2025: China Export Review, Blackwell “Cloud Loophole,” and 2026 Catalysts

NVIDIA Stock (NVDA) News, Forecasts and Analyst Outlook After Dec. 20, 2025: China Export Review, Blackwell “Cloud Loophole,” and 2026 Catalysts

NVIDIA Corporation is heading into the final full stretch of 2025 with investors juggling two forces that regularly drive the stock: AI infrastructure demand and geopolitics around China. Over the weekend of December 20, 2025, NVDA became the center of a fresh round of headlines—from reports that China’s Tencent may be accessing restricted Blackwell chips via overseas cloud providers, to Wall Street analysts calling Nvidia “cheap” by its own historical standards, to renewed speculation around what 2026 catalysts could restart the next leg higher. Barron's+2Investors+2
21 December 2025
·
AbbVie Stock (ABBV) Outlook: Drug‑Pricing Deal Headlines, Fresh Analyst Targets, and the 2026 Catalysts Investors Are Watching

AbbVie Stock (ABBV) Outlook: Drug‑Pricing Deal Headlines, Fresh Analyst Targets, and the 2026 Catalysts Investors Are Watching

December 21, 2025 — AbbVie Inc. heads into the final stretch of 2025 near multi‑month highs, but the weekend news cycle has put a familiar theme back in the spotlight: U.S. drug pricing policy. At the same time, Wall Street’s newest notes show a market still split between strong fundamentals and policy/pipeline debates that could shape sentiment into 2026.
21 December 2025
··
1 … 711 712 713 714 715 … 880

Stock Market Today

  • FIIs Inch Back Into Indian Equities but Caution Lingers
    July 10, 2026, 11:26 PM EDT. Foreign Institutional Investors (FIIs) are putting money into Indian stocks again after staying out for four months. Analysts say market fundamentals haven't really improved much. Recent inflows are being linked to optimism around artificial intelligence (AI) and geopolitics, but some experts call these drivers superficial with India's equities still weak over the last two years. The FII move shows some return of confidence, but most see the market's core issues remaining.
Go toTop